[go: up one dir, main page]

FI932144L - Nucleic acid amplification med ett oavbrutet sekvensreplicationssystem vooren tvao enzymer - Google Patents

Nucleic acid amplification med ett oavbrutet sekvensreplicationssystem vooren tvao enzymer Download PDF

Info

Publication number
FI932144L
FI932144L FI932144A FI932144A FI932144L FI 932144 L FI932144 L FI 932144L FI 932144 A FI932144 A FI 932144A FI 932144 A FI932144 A FI 932144A FI 932144 L FI932144 L FI 932144L
Authority
FI
Finland
Prior art keywords
sekvensreplicationssystem
oavbrutet
vooren
enzymer
tvao
Prior art date
Application number
FI932144A
Other languages
Finnish (fi)
Other versions
FI932144A0 (en
Inventor
Eoin David Fahy
Deborah Yantis Kwoh
Thomas Raymond Gingeras
Original Assignee
Siska Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siska Diagnostics Inc filed Critical Siska Diagnostics Inc
Publication of FI932144A0 publication Critical patent/FI932144A0/en
Publication of FI932144L publication Critical patent/FI932144L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
FI932144A 1990-11-13 1993-05-12 Nucleic acid amplification med ett oavbrutet sekvensreplicationssystem vooren tvao enzymer FI932144L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61268890A 1990-11-13 1990-11-13

Publications (2)

Publication Number Publication Date
FI932144A0 FI932144A0 (en) 1993-05-12
FI932144L true FI932144L (en) 1993-05-12

Family

ID=24454235

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932144A FI932144L (en) 1990-11-13 1993-05-12 Nucleic acid amplification med ett oavbrutet sekvensreplicationssystem vooren tvao enzymer

Country Status (13)

Country Link
EP (1) EP0572417A4 (en)
JP (1) JPH06502767A (en)
AU (1) AU9131591A (en)
CA (1) CA2096013A1 (en)
FI (1) FI932144L (en)
HU (1) HUT69772A (en)
IE (1) IE913930A1 (en)
IL (1) IL100040A (en)
NO (1) NO931709L (en)
NZ (1) NZ240574A (en)
PT (1) PT99500A (en)
WO (1) WO1992008800A1 (en)
ZA (1) ZA918965B (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5673794A (en) * 1992-11-19 1994-06-08 Matthew C. Biery Production of monoclonal recombinant antibodies without the use of hybridomas by (in vitro) spleen fragment culture combined with isothermal self-sustained sequence replication of rna
DE69431240T2 (en) * 1993-12-01 2003-04-17 Toyo Boseki K.K., Osaka METHOD FOR AMPFLIFICATING AND DETECTING CERTAIN NUCLEIC ACID SEQUENCES BY MEANS OF THERMOSTABLE ENZYMS
US5705366A (en) * 1994-09-15 1998-01-06 Johnson & Johnson Clinical Diagnostics, Inc. Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
JPH08131171A (en) * 1994-11-11 1996-05-28 Asahi Chem Ind Co Ltd Reverse transcriptase-stabilized composition
US5763184A (en) 1996-01-30 1998-06-09 Roche Molecular Systems, Inc. Nucleotide sequence variation in the ABO glycosyltransferase gene
WO2000000638A2 (en) * 1998-06-26 2000-01-06 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
JP2001029078A (en) * 1999-07-16 2001-02-06 Shimadzu Corp Amplification of rna
AU2001278517A1 (en) 2000-08-03 2002-02-18 F. Hoffman-La Roche Ag Nucleic acid binding compounds containing pyrazolo(3,4-d)pyrimidine analogues of purin-2,6-diamine and their uses
US6780588B2 (en) 2001-05-07 2004-08-24 Applera Corporation Methods for the reduction of stutter in microsatellite amplification
US6841349B2 (en) 2001-05-07 2005-01-11 Applera Corporation Applied Biosystems Group Methods for the reduction of stutter in microsatellite amplification
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
ES2294287T5 (en) 2002-01-08 2015-10-27 F. Hoffmann-La Roche Ag Use of a silica material in an amplification reaction
WO2003064679A2 (en) 2002-01-30 2003-08-07 Id Biomedical Corporation Methods for detecting vancomycin-resistant microorganisms and compositions therefor
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
DE10240868A1 (en) * 2002-09-04 2004-03-18 Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH Improved procedures for the synthesis of nucleic acids
DE602004009038T3 (en) 2003-01-29 2015-06-25 Roche Diagnostics Gmbh Improved bisulfite treatment method
JP2004357502A (en) * 2003-05-30 2004-12-24 Olympus Corp Method for processing information using nucleic acid molecule
EP1767655A4 (en) 2004-07-13 2007-08-01 Takeda Pharmaceutical METHOD OF CONTROLLING THE FUNCTIONS OF A CELL
EP1632578A1 (en) 2004-09-03 2006-03-08 Roche Diagnostics GmbH DNA decontamination method
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
US8420315B2 (en) 2007-08-06 2013-04-16 Orion Genomics Llc Single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene
CA2639416C (en) 2007-09-11 2019-12-31 F. Hoffmann-La Roche Ag Diagnostic test for susceptibility to b-raf kinase inhibitors
AU2008318316B2 (en) 2007-11-01 2015-08-06 University Of Iowa Research Foundation RCA locus analysis to assess susceptibility to AMD and MPGNII
EP2955234A1 (en) 2009-02-11 2015-12-16 Orion Genomics, LLC Combinations of polymorphisms for determining allele-specific expression of igf2
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
WO2011153254A2 (en) 2010-06-04 2011-12-08 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
US20140004510A1 (en) 2010-09-24 2014-01-02 Massachusetts Eye And Ear Infirmary Methods and compositions for prognosing and/or detecting age-related macular degeneration
WO2012054727A1 (en) 2010-10-22 2012-04-26 Bio-Rad Laboratories, Inc. Reverse transcriptase mixtures with improved storage stability
SG10201607224PA (en) 2011-08-31 2016-10-28 Hoffmann La Roche Responsiveness to Angiogenesis Inhibitors
SG2014008585A (en) 2011-08-31 2014-04-28 Hoffmann La Roche Method for predicting risk of hypertension associated with anti-angiogenesis therapy
US20130078252A1 (en) 2011-09-19 2013-03-28 Genentech, Inc. Combination treatments comprising c-met antagonists and b-raf antagonists
ES2729554T3 (en) 2011-10-21 2019-11-04 Chronix Biomedical Biomarkers of circulating nucleic acids associated with colorectal cancer
MX2014006186A (en) 2011-11-23 2014-07-14 Hoffmann La Roche Responsiveness to angiogenesis inhibitors.
US9115394B2 (en) 2011-12-22 2015-08-25 Roche Molecular Systems, Inc. Methods and reagents for reducing non-specific amplification
EP3004388B2 (en) 2013-05-29 2023-05-31 Chronix Biomedical Detection and quantification of donor cell-free dna in the circulation of organ transplant recipients
EP3572093A1 (en) 2014-03-31 2019-11-27 Debiopharm International SA Fgfr fusions
US11708608B2 (en) 2014-11-10 2023-07-25 Genentech, Inc. Therapeutic and diagnostic methods for IL-33-mediated disorders
CN107849603B (en) 2015-04-24 2022-01-28 阿提拉生物系统公司 Amplification of primers with limited nucleotide composition
ES2741782T3 (en) 2015-08-17 2020-02-12 Kura Oncology Inc Methods for treating cancer patients from farnesyltransferase inhibitors
US20190119758A1 (en) 2016-04-22 2019-04-25 Kura Oncology, Inc. Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
EA201991091A1 (en) 2016-11-03 2019-11-29 WAYS OF TREATMENT OF PATIENTS WITH MALIGNANT NEW FORMATIONS USING PHARNESYL TRANSFERASE INHIBITORS
US9956215B1 (en) 2017-02-21 2018-05-01 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
ES2927228T3 (en) 2017-02-21 2022-11-03 Kura Oncology Inc Methods of treating cancer with farnesyl transferase inhibitors
MX2020001207A (en) 2017-08-07 2020-03-20 Kura Oncology Inc Methods of treating cancer with farnesyltransferase inhibitors.
US10806730B2 (en) 2017-08-07 2020-10-20 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
KR20220098056A (en) 2018-02-09 2022-07-08 제넨테크, 인크. Therapeutic and diagnostic methods for mast cell-mediated inflammatory diseases
AU2019372141A1 (en) 2018-11-01 2021-05-27 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US20220142983A1 (en) 2019-03-01 2022-05-12 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
AU2020254492A1 (en) 2019-03-29 2021-11-11 Kura Oncology, Inc. Methods of treating Squamous Cell Carcinomas with farnesyltransferase inhibitors
WO2020205387A1 (en) 2019-04-01 2020-10-08 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
WO2020223583A1 (en) 2019-05-02 2020-11-05 Kura Oncology, Inc. Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
CN115315527A (en) 2020-03-13 2022-11-08 免疫医疗有限公司 Methods of treatment for subjects with at risk alleles in IL33
WO2024015331A1 (en) 2022-07-12 2024-01-18 Genentech, Inc. Therapeutic and diagnostic methods for multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
CA1340807C (en) * 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
BR8907830A (en) * 1988-12-16 1991-10-22 Siska Diagnostics Inc PROCESS FOR PREPARING A DOUBLE-FILAMENT DNA THAT CODES A SEQUENCE THAT MATCHES A OBJECTIVE NUCLEIC ACID SEQUENCE AND PROCESS USED FOR DETECTION OF AT LEAST ONE SPECIFIC OBJECTIVE NUCLEIC ACID SEQUENCE
US5480784A (en) * 1989-07-11 1996-01-02 Gen-Probe Incorporated Nucleic acid sequence amplification methods

Also Published As

Publication number Publication date
JPH06502767A (en) 1994-03-31
FI932144A0 (en) 1993-05-12
IL100040A (en) 1995-12-31
HU9301369D0 (en) 1993-10-28
EP0572417A4 (en) 1994-11-23
EP0572417A1 (en) 1993-12-08
ZA918965B (en) 1992-08-26
NO931709D0 (en) 1993-05-11
NO931709L (en) 1993-07-12
CA2096013A1 (en) 1992-05-14
WO1992008800A1 (en) 1992-05-29
HUT69772A (en) 1995-09-28
IE913930A1 (en) 1992-06-17
IL100040A0 (en) 1992-08-18
AU9131591A (en) 1992-06-11
PT99500A (en) 1992-10-30
NZ240574A (en) 1994-10-26

Similar Documents

Publication Publication Date Title
FI932144L (en) Nucleic acid amplification med ett oavbrutet sekvensreplicationssystem vooren tvao enzymer
DK0519338T3 (en) Improved Methods for Nucleic Acid Amplification
FI882663A (en) BESTAEMNING AV VOLYMEN AV ETT MATERIALSKIKT MED HJAELP AV ETT KORREKTIONSBAND.
FI925207A0 (en) EN MED ETT ILLUMINERANDE MEMBRAN FOERSEDD BRYTARE MED REDUCERAD STORLEKOCH FOERBAETTRADE ILLUMINERINGSEGENSKAPER
FI913322A0 (en) MELLANLAEGG FOER LUFTVAEGARNA FOER ANVAENDNING MED ETT TILLSLUTET SUGKATETERSYSTEM.
FI924646A (en) OEVERSPAENNINGS- OCH OEVERSTROEMMSSKYDD FOER ETT LINJEOEVERDRAG
FI900889A0 (en) FLUORESCENSLAMPA MED ETT ULTRAVIOLET-REFLEKTERANDE SKIKT.
FI880817A0 (en) ANORDNING FOER KOPPLING MED LAOG FOERLUST AV ETT HALVLEDARKOPPLINGSELEMENT I EN TREPUNKTVAEXELRIKTARE.
FI953079L (en) DNA amplification
FI884781A (en) STAENGBAR BEHAOLLARE MED ETT I EN VAETSKA DOPPAT SKURSTYCKE FOER BEHANDLING AV FINGRAR.
FI883352L (en) ANVAENDNING AV DUBBELSTRAENGAD RNA FOER FRAMSTAELLNING AV ETT LAEKEMEDEL FOER BEHANDLING AV INFLAMMATIONER.
FI881151A0 (en) ELEKTROLUMINESCENT DISPLAY MED ETT MELLANSKIKT FOER FOERBAETTRAD FORMNING.
FI931824A (en) PRESSANORDNING MED ETT FOERLAENGT NYP
FI894654L (en) LINJEAVBOEJNINGSKRETS FOER ETT BILDROER.
FI881933L (en) TILL ETT PUMPHUS ANSLUTEN DOSERARE.
FI906235A0 (en) FOER ETT FORDON AVSETT DRAGKROKSUPPSAETTNING MED EN LOESTAGBAR DRAGKROK.
NO940658L (en) Nucleic acid polymerase amplification
FI884694L (en) FOERFARANDE FOER TILLVERKNING AV ETT KAERL FOER EN LAETTVATTENSKAERNREAKTOR OCH ETT KAERNREAKTORKAERL TILLVERKAT MED ANVAENDANDE AV DETTA FOERFARANDE.
FI882038L (en) HYDRAULVENTIL MED ETT SYSTEM FOER KONTROLLERING AV KOLVENS LAEGE.
FI883211A (en) FORDON MED DRIVANDE HJUL DRIVNA AV HYDRAULISKA MOTORER OCH ETT HYDRAULISKT STYRSYSTEM.
FI913814A0 (en) LAESKE DRYCKSBEHAOLLARE MED ETT NYTT DISTRIBUTIONSDON.
FI910153A (en) JUSTERBARA LAOSKILAR I ETT KIPPLAUFVAPEN MED EN OEVERSPAKSLAOSNING.
FI870710A0 (en) MED HJUL FOERSEDD FLYTTANORDNING FOER FLYTTNING AV ETT FLYGPLAN.
FI885442A (en) DRIFTKOPPLINGSANORDNING FOER ETT NYTTOFORDON.
FI920885L (en) PAOVISANDE AV BAKTERIER MED BISTAOND AV EN NUCLEINS ACID AMPLIFICATION

Legal Events

Date Code Title Description
FD Application lapsed